Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer

被引：0
|
作者：
Meliha Mehmeti
Roni Allaoui
Caroline Bergenfelz
Lao H. Saal
Stephen P. Ethier
Martin E. Johansson
Karin Jirström
Karin Leandersson
机构：
[1] Lund University,Center for Molecular Pathology, Department of Translational Medicine
[2] Lund University,Division of Oncology and Pathology, Department of Clinical Sciences
[3] Medical University of South Carolina,Department of Pathology and Laboratory Medicine, Hollings Cancer Center
来源：
Breast Cancer Research | / 17卷
关键词：
Breast Cancer; Estrogen Receptor; Breast Cancer Cell; TLR4 Expression; TLR4 Protein Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Does estrogen receptor-negative/progesterone receptor-positive breast carcinoma exist? Reply
    Rakha, Emad A.
    Ellis, Ian O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 336 - 338
  • [32] Estrogen receptor-negative, progesterone receptor-positive breast carcinoma - Poor clinical outcome
    Keshgegian, AA
    Cnaan, A
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1996, 120 (10) : 970 - 973
  • [33] Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype - Discussion
    Kuo, PC
    Carmeci
    Cance, WG
    SURGERY, 1998, 124 (02) : 217 - 217
  • [34] Vitamin D induces expression of estrogen receptor and restores endocrine therapy response in estrogen receptor-negative breast cancer
    Santos, N.
    Diaz, L.
    Ordaz, D.
    Garcia, J.
    Barrera, D.
    Avila, E.
    Halhali, A.
    Medina, H.
    Camacho, J.
    Larrea, F.
    Garcia, R.
    CANCER RESEARCH, 2012, 72
  • [35] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Wu, Lunpo
    Wang, Qinghua
    Zhou, Shishi
    Tang, Wanfen
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Hong, Zhongwu
    Fu, Jianfei
    Du, Jinlin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1145 - 1153
  • [36] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Hongjuan Zheng
    Chenyang Ge
    Haiping Lin
    Lunpo Wu
    Qinghua Wang
    Shishi Zhou
    Wanfen Tang
    Xia Zhang
    Xiayun Jin
    Xifeng Xu
    Zhongwu Hong
    Jianfei Fu
    Jinlin Du
    International Journal of Clinical Oncology, 2022, 27 : 1145 - 1153
  • [37] Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients
    Yang, Li-Heng
    Tseng, Hsin-Shun
    Lin, Che
    Chen, Li-Sheng
    Chen, Shou-Tung
    Kuo, Shou-Jen
    Chen, Dar-Ren
    JOURNAL OF BREAST CANCER, 2012, 15 (03) : 288 - 295
  • [38] Akt activation by estrogen in estrogen receptor-negative breast cancer cells
    Tsai, EM
    Wang, SC
    Lee, JN
    Hung, MC
    CANCER RESEARCH, 2001, 61 (23) : 8390 - 8392
  • [39] Estrogen accelerates the development of estrogen receptor-negative breast cancer.
    Zhao, Hong
    Coon, John S.
    Chatterton, Robert T.
    Huberts, Dolores
    Brooks, David Christopher
    DeMayo, Francesco J.
    Bulun, Serdar E.
    CANCER RESEARCH, 2013, 73 (08)
  • [40] HER2 expression in Brazilian patients with estrogen and progesterone receptor-negative breast carcinoma
    Ramalho, Susana
    Serra, Katia Piton
    Vassallo, Jose
    Soares, Fernando Augusto
    Pinto, Glauce Aparecida
    Teixeira, Luiz Carlos
    da Cunha, Isabela Werneck
    Derchain, Sophie F. M.
    de Souza, Gustavo
    ACTA HISTOCHEMICA, 2013, 115 (02) : 120 - 127
12345